Hailiang Xue - Tianan Pharmaceutical Chief Production Officer
| TNPH Stock | USD 0.01 0.00 0.00% |
Executive
Mr. Xue is Chief Production Officer of Tianan Pharmaceutical Co since December 2003. Between 1999 and 2002 Mr. Xue was the Chief Production Officer of Shaanxi Hualong Pharmaceutical Limited Company, a firm engaged in the production and sale of TCM products. since 2003.
| Age | 56 |
| Tenure | 21 years |
| Phone | 86 29 8538 1587 |
| Web | http://www.Xatazy.com |
Tianan Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.1801 % which means that it generated a profit of $0.1801 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2512 %, meaning that it created $0.2512 on every $100 dollars invested by stockholders. Tianan Pharmaceutical's management efficiency ratios could be used to measure how well Tianan Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MSc BBA | Immutep Ltd ADR | N/A | |
| Kimberly Scholtz | Provident Bancorp | N/A | |
| Matthew Gregorowski | Immutep Ltd ADR | N/A | |
| Asaf Berenstin | Formula Systems 1985 | 46 | |
| Jason Fredette | Mersana Therapeutics | N/A | |
| Janine Jakubauskas | Provident Bancorp | N/A | |
| Yaffa CohenIfrah | Formula Systems 1985 | N/A | |
| Carlos Doormann | Betterware De Mexico | 53 | |
| John Batson | Home Federal Bancorp | N/A | |
| Patricia Allison | Marker Therapeutics | N/A | |
| Marc Damelin | Mersana Therapeutics | N/A | |
| Alejandro Miranda | Betterware De Mexico | N/A | |
| Dirk Huebner | Mersana Therapeutics | N/A | |
| Anne Lapointe | Provident Bancorp | N/A | |
| Eva Jack | Mersana Therapeutics | 49 | |
| Pilar Sanchez | Betterware De Mexico | N/A | |
| Edmund Cheung | Marker Therapeutics | N/A | |
| Reynaldo VizcarraMendez | Betterware De Mexico | 58 | |
| Jean Kim | Provident Bancorp | 50 | |
| Frederic Triebel | Immutep Ltd ADR | 60 | |
| Mauricio Alvarez | Betterware De Mexico | 54 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 |
Tianan Pharmaceutical Leadership Team
Elected by the shareholders, the Tianan Pharmaceutical's board of directors comprises two types of representatives: Tianan Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tianan. The board's role is to monitor Tianan Pharmaceutical's management team and ensure that shareholders' interests are well served. Tianan Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tianan Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Deshun Li, Director | ||
| Lie Wei, Chief Officer | ||
| Jianjun Weng, CEO and Director | ||
| Yanqing Wang, Director | ||
| Peng Xi, Chief Marketing Officer | ||
| Ning Jia, Director | ||
| Renhua Wang, Secretary | ||
| Mingqi Sun, Chief Quality Officer | ||
| Zhiguo Ma, Director | ||
| Hailiang Xue, Chief Production Officer | ||
| Ping Ren, Director | ||
| Andong Jia, Chief Admin. Officer | ||
| Huachu Tang, Chief Investment Officer | ||
| Wei Li, Chief Financial and Accounting Officer | ||
| Jinming Gao, Director | ||
| Hongwei Wang, Director |
Tianan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Tianan Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.36 % | |||
| Current Valuation | 979.64 K | |||
| Price To Earning | 0.15 X | |||
| Price To Book | 1.20 X | |||
| Price To Sales | 1.62 X | |||
| Revenue | 10.65 M | |||
| Gross Profit | 7.3 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tianan Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tianan Pharmaceutical's short interest history, or implied volatility extrapolated from Tianan Pharmaceutical options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tianan Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Tianan Pink Sheet analysis
When running Tianan Pharmaceutical's price analysis, check to measure Tianan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tianan Pharmaceutical is operating at the current time. Most of Tianan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Tianan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tianan Pharmaceutical's price. Additionally, you may evaluate how the addition of Tianan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |